Related Experiment Video
Updated: Jun 12, 2026
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality
1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Abstract:
A major goal of tumor suppressor research is to neutralize the tumorigenic effects of their loss. Since loss of pRb does not induce tumorigenesis in many types of cells, natural mechanisms may neutralize the tumorigenic effects of pRb loss in these cells. For susceptible cells, neutralizing the tumorigenic effects of pRb loss could logically be achieved by correcting the deregulated activities of pRb targets to render pRb-deficient cells less abnormal. This line of research has unexpectedly revealed that knocking out the pRb target Skp2 did not render Rb1 deficient cells less abnormal but, rather, induced apoptosis in them, thereby completely blocking tumorigenesis in Rb1+/- mice and after targeted deletion of Rb1 in pituitary intermediate lobe (IL). Skp2 is a substrate-recruiting component of the SCFSkp2 E3 biquitin ligase; one of its substrates is Thr187-phosphorylated p27Kip1. A p27T187A knockin (KI) mutation phenocopied Skp2 knockout (KO) in inducing apoptosis following Rb1 loss. Thus, Skp2 KO or p27T187A KI are synthetic lethal with pRb inactivation. Since homozygous p27T187A KI mutations show no adverse effects in mice, inhibiting p27T187 phosphorylation or p27T187p ubiquitination could be a highly therapeutic and minimally toxic intervention strategy for pRb deficiency-induced tumorigenesis.
Insights
Researchers found that inhibiting Skp2 or a specific p27Kip1 modification blocks tumor formation caused by the loss of the pRb tumor suppressor. This offers a potential low-toxicity cancer therapy strategy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The loss of the retinoblastoma protein (pRb) tumor suppressor can lead to cancer.
- Natural cellular mechanisms can sometimes counteract the effects of pRb loss.
- Targeting pRb targets is a potential strategy to correct abnormalities in pRb-deficient cells.
Purpose of the Study:
- To investigate methods for neutralizing the tumorigenic effects of pRb loss.
- To explore the role of pRb targets, specifically Skp2, in pRb-deficient cells.
- To identify potential therapeutic strategies for pRb deficiency-induced tumorigenesis.
Main Methods:
- Studied the effects of Skp2 knockout (KO) in Rb1-deficient mouse models.
- Utilized a p27Kip1 knockin (KI) mutation (p27T187A) to mimic Skp2 KO effects.
- Assessed tumor formation and apoptosis in genetically modified mice.
Main Results:
- Skp2 knockout did not correct abnormalities in Rb1-deficient cells but induced apoptosis, blocking tumorigenesis.
- The p27T187A KI mutation phenocopied Skp2 KO, inducing apoptosis upon Rb1 loss.
- Skp2 KO and p27T187A KI were found to be synthetically lethal with pRb inactivation.
- Homozygous p27T187A KI mutations showed no adverse effects in mice.
Conclusions:
- Inhibiting p27Kip1 phosphorylation or ubiquitination represents a promising therapeutic strategy for pRb deficiency-driven cancers.
- This approach offers a potentially highly effective and minimally toxic intervention for specific tumor types.
- The synthetic lethality between pRb inactivation and p27T187 modification provides a novel therapeutic window.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...